Early experience with Watson for oncology in Korean patients with colorectal cancer.
Eui Joo KimHyun Sun WooJae Hee ChoSun Jin SymJeong-Heum BaekWon-Suk LeeKwang An KwonKyoung Oh KimJun-Won ChungDong Kyun ParkYoon Jae KimPublished in: PloS one (2019)
The concordance rate between chemotherapy regimens for colorectal cancer determined by MDT versus WFO recommendations was 46.4%. After including the 'For consideration' category from WFO, the concordance rate increased to 88.4%. Further modification and improvement of the WFO prioritizing algorithm used to recommend treatment may increase the usefulness of WFO in the clinic.